Company Filing History:
1 out of 12 
1 out of 1 Years Active: 2013
Title: Maria Denise Fernandes Carvalho: Innovator in Analgesic Treatments
Introduction
Maria Denise Fernandes Carvalho is a prominent inventor based in Fortaleza, Brazil. She has made significant contributions to the field of medicine, particularly in the development of innovative analgesic treatments. Her work focuses on the use of telocinobufagin, a compound that has shown promise in alleviating acute and chronic pain.
Latest Patents
Maria Denise holds a patent for the use of telocinobufagin as an analgesic in the treatment of acute and chronic pains. The invention is directed towards the manufacture of a medicament that utilizes telocinobufagin or its pharmaceutically acceptable derivatives. This pharmaceutical composition comprises an effective amount of telocinobufagin, which has been shown to induce analgesia in both humans and animals. In vivo assays indicate that telocinobufagin is more potent than morphine, without the side effects commonly associated with opioids. Furthermore, studies have demonstrated that telocinobufagin does not present cardiotoxicity.
Career Highlights
Throughout her career, Maria Denise has worked with notable companies such as Cristalia Produtos Quimicos Farmaceuticos Ltda. and Genpharma Consultoria Farmaceutica e Genetica Ltda. Her expertise in pharmacology and her innovative approach to pain management have positioned her as a leader in her field.
Collaborations
Maria Denise has collaborated with esteemed colleagues, including Krishnamurti De Morais Carvalho and Dòris Maria Fernandes Carvalho. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Maria Denise Fernandes Carvalho is a trailblazer in the field of analgesic treatments, with her innovative use of telocinobufagin paving the way for new pain management solutions. Her contributions to medicine are invaluable, and her work continues to inspire future advancements in the field.